Oncolyze, Inc.
Pharmaceutical company · New York, United States
Oncolyze, Inc. is a pharmaceutical company headquartered in New York, United States. It has reported private securities offerings to the US SEC, most recently $425,000 sold in a notice filed in 2022.
Profile compiled from public records. Is this your company? Request a correction or update
Oncolyze at a glance
Typepharmaceutical company
HeadquartersNew York, United States
SEC industryPharmaceutical Preparations
SEC CIK1917375
What does Oncolyze do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $425,000 sold (2022).
Frequently asked questions about Oncolyze
Where is Oncolyze headquartered?
Oncolyze, Inc. is headquartered in New York, United States.
What does Oncolyze do?
Oncolyze, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences